Xiu Mei Tao
Fondateur chez NKD Pharma Co., Ltd.
Profil
Xiu Mei Tao is the founder of NKD Pharma Co., Ltd.
which was founded in 2013.
She held the title of General Manager & Director at the company since 2014.
Dr. Tao has a doctorate degree from Shanghai Jiao Tong University, a graduate degree from Shenyang Pharmaceutical University, and an undergraduate degree from Jiamusi.
Postes actifs de Xiu Mei Tao
| Sociétés | Poste | Début |
|---|---|---|
NKD Pharma Co., Ltd.
 NKD Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology NKD Pharma Co., Ltd. engages in the provision of entrusted research and development services, and independent project research and development services. Its entrusted research and development services cover pharmaceutical research, non-clinical research, and clinical research services for pharmaceutical companies and pharmaceutical research and development investment companies. Its independent project research and development services encompass generic drug, medical devices, and special medical food development services. The company was founded by Peng Chen, Xiu Mei Tao, Chun Peng Wang, and Ke Min Li on July 23, 2013 and is headquartered in Beijing, China. | Fondateur | 23/07/2013 |
Formation de Xiu Mei Tao
| Jiamusi | Undergraduate Degree |
| Shenyang Pharmaceutical University | Graduate Degree |
| Shanghai Jiao Tong University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
NKD Pharma Co., Ltd.
NKD Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology NKD Pharma Co., Ltd. engages in the provision of entrusted research and development services, and independent project research and development services. Its entrusted research and development services cover pharmaceutical research, non-clinical research, and clinical research services for pharmaceutical companies and pharmaceutical research and development investment companies. Its independent project research and development services encompass generic drug, medical devices, and special medical food development services. The company was founded by Peng Chen, Xiu Mei Tao, Chun Peng Wang, and Ke Min Li on July 23, 2013 and is headquartered in Beijing, China. | Health Technology |
